AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8450166
Drug: Clentiazem 120
RxNorm normalized name: diltiazem hydrochloride Extended Release Oral Capsule [Kentiazem]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clentiazem 120 mg/day
Trial: 28110287
Drug: Daily low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily low-dose aspirin (100 mg)
Trial: 19804443
Drug: House dust
RxNorm normalized name: House dust
DrugBank: House dust (DB10345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: House dust mite (HDM) allergen inhalation challenge
Trial: 19804443
Drug: Grass pollen
RxNorm normalized name: grass pollen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass pollen (GP) allergen inhalation challenge
Trial: 9323286
Drug: Single-dose prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose prednisolone (2 mg/kg per day as a single morning dose for 2 weeks, followed by 1.5 mg/kg on alternate days for 4 weeks)
Trial: 9323286
Drug: Divided-dose prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divided-dose prednisolone (2 mg/kg per day in three divided doses for 2 weeks, followed by 1.5 mg/kg on alternate days for 4 weeks)
Trial: 9323286
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (single-dose and divided-dose)
Trial: 31391092
Drug: Yinang formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yinang formulation (YNF) plus conventional therapy
Trial: 28777672
Drug: Grounded khat
RxNorm normalized name: Turmeric,ground
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grounded khat leaves extract (45 g)
Trial: 26952221
Drug: 0.1mg intrathecal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1mg intrathecal morphine (Group I, n=22)
Trial: 26952221
Drug: 0.4mg intrathecal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4mg intrathecal morphine (Group II, n=26)
Trial: 21931327
Drug: Family-based behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-based behavioural treatment (FBBT)
Trial: 18572432
Drug: Rizatriptan 10
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rizatriptan 10 mg + Acetaminophen 1000 mg (RA)
Trial: 18572432
Drug: Acetaminophen alone
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen alone (A)
Trial: 9142805
Drug: Trimethoprim-sulfamethoxazole (TMP-SMZ;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole (TMP-SMZ; 5/25 mg/[kg x d])
Trial: 28086943
Drug: Whole-grain rye
RxNorm normalized name: rice (whole grain) allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-grain rye intake (170 g/day) and vigorous physical activity (3 × 45 minutes/week) for 6 months
Trial: 24366918
Drug: Mipomersen 200
RxNorm normalized name: mipomersen 200 mg/mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen 200 mg weekly
Trial: 21912474
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg twice daily for 2 weeks, amoxicillin 1.0 g and clarithromycin 0.5 g twice daily for 1 week
Trial: 21912474
Drug: Rabeprazole, amoxicillin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole, amoxicillin, and clarithromycin
Trial: 19138183
Drug: Oral‐B CrossAction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral‐B CrossAction (CA) used for 1 min
Trial: 10975769
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg once daily for 12 weeks
Trial: 10975769
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg once daily for 12 weeks (only patients with normal mucosa at baseline)
Trial: 10975769
Drug: Placebo once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo once daily for 12 weeks (only patients with normal mucosa at baseline)
Trial: 8931749
Drug: T-activin therapy
RxNorm normalized name: Neoantigen specific TCR-T cell therapy
DrugBank: Neoantigen specific TCR-T cell therapy (DB17458)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-activin therapy
Trial: 1306672
Drug: Oral-B 40
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral-B 40 toothbrush
Trial: 22009784
Drug: Medial-sided augmentation
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medial-sided augmentation (MSA)
Trial: 22009784
Drug: Lateral-sided augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral-sided augmentation (LSA)
Trial: 16106120
Drug: Left ventricular
RxNorm normalized name: DRESSING,VENTRICULAR ASSIST DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left ventricular assist device therapy
Trial: 9412304
Drug: Norfloxacin, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin, 400 mg twice daily, for 4 weeks
Trial: 2059974
Drug: Oral fluoride
RxNorm normalized name: sodium fluoride Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluoride pharmacokinetics
Trial: 6131254
Drug: Solarium exposure
RxNorm normalized name: scoparium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solarium exposure (suntan treatment)
Trial: 6131254
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (age and sex matched concurrent controls)
Trial: 25186131
Drug: Flexible incobotulinumtoxinA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible incobotulinumtoxinA (Xeomin®) injections at intervals of 6-20 weeks, with doses of ≤ 50 U/eye for blepharospasm and 120 U or 240 U for CD.
Trial: 11250995
Drug: Fenretinide treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenretinide treatment (5-year duration)
Trial: 9648698
Drug: Intranasal fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal fluticasone propionate (FP) 200 microg four times daily for 6 days
Trial: 15176496
Drug: Intranasal fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal fluticasone propionate (FP)
Trial: 7978538
Drug: Inhaled beta‐adrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beta‐adrenergic agonists
Trial: 2537582
Drug: Baclofen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (30 mg/day for 4 weeks)
Trial: 31264940
Drug: Transdiagnostic cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdiagnostic cognitive-behavioral therapy (CBT) for anxiety
Trial: 21205247
Drug: Intravenous tissue
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tissue plasminogen activator at 0.9 mg/kg
Trial: 21205247
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline) 100 ml
Trial: 18285727
Drug: CMV IgM
RxNorm normalized name: CMV-immune globulin
DrugBank: Human cytomegalovirus immune globulin (DB13886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMV IgM antibody
Trial: 8686975
Drug: Norfloxacin, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin, 400 mg every 12 hours
Trial: 8686975
Drug: Ofloxacin, 400
RxNorm normalized name: Ofloxacin, 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin, 400 mg every 12 hours
Trial: 8686975
Drug: Ofloxacin, 400
RxNorm normalized name: Ofloxacin, 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin, 400 mg, plus rifampin, 300 mg every 12 hours
Trial: 2051576
Drug: M1-blocker; pirenzepine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M1-blocker; pirenzepine
Trial: 2051576
Drug: H2-blocker; ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-blocker; ranitidine
Trial: 30394006
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (AA) supplementation (2 × 500 mg/d)
Trial: 16542056
Drug: MK‐0767 (1-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK‐0767 (1-80 mg single doses)
Trial: 16542056
Drug: MK‐0767 (0.3-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK‐0767 (0.3-25 mg multiple doses once daily for 14 days)
Trial: 16542056
Drug: MK‐0767 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK‐0767 (25 mg multiple doses once daily for 14 days)
Trial: 10940094
Drug: Solubilized ibuprofen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solubilized ibuprofen, 400 mg
Trial: 10940094
Drug: Acetaminophen, 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen, 1000 mg
Trial: 3484773
Drug: Cefadroxil, 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil, 1,000 mg single‐dose
Trial: 3484773
Drug: Cefadroxil, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil, 500 mg twice a day for three days
Trial: 3484773
Drug: Cefadroxil, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil, 500 mg twice a day for seven days
Trial: 3484773
Drug: Trimethoprim‐sulfamethoxazole (TMP‐SMZ),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim‐sulfamethoxazole (TMP‐SMZ), 320‐1,600 mg single‐dose
Trial: 3484773
Drug: Trimethoprim‐sulfamethoxazole (TMP‐SMZ),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim‐sulfamethoxazole (TMP‐SMZ), 160‐800 mg twice a day for three days
Trial: 26508702
Drug: 15LEU (70/15/180/30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15LEU (70/15/180/30 g protein-leucine-carbohydrate-fat)
Trial: 26508702
Drug: 5LEU (23/5/180/30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5LEU (23/5/180/30 g protein-leucine-carbohydrate-fat)
Trial: 16697496
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acid enriched parenteral nutrition
Trial: 8746285
Drug: L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (2 g/day) for 28 days
Trial: 1402620
Drug: Prednisolone, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone, 25 mg orally, three times daily for 8 days
Trial: 3768084
Drug: Preparation A
RxNorm normalized name: POVIDONE-IODINE 75 mg in 1 mL TOPICAL SOLUTION [Antiseptic Patient Preoperative Skin Preparation and Surgical Hand Scrub]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation A (Salbutax)
Trial: 3768084
Drug: Preparation B
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation B (commercially available formulation)
Trial: 31642985
Drug: Food-related behavioral
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food-related behavioral activation therapy (F-BA) for 12 months
Trial: 21297126
Drug: Concurrent radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent radiation therapy (RT) with gefitinib and tipifarnib
Trial: 27945892
Drug: Vaccine containing
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine containing Mycobacterium w, administered 0.1 ml intradermally on a weekly basis for 6 to 10 weeks.
Trial: 27945892
Drug: Vaccine containing
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine containing Mycobacterium w
Trial: 12017405
Drug: Clarithromycin ER
RxNorm normalized name: Clarithromycin ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin ER (two 500-mg tablets once daily for 7 days)
Trial: 12017405
Drug: Trovafloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin (200 mg once daily for 7 days)
Trial: 8018004
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of heparin nomogram
Trial: 8018004
Drug: Heparin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin therapy with nomogram
Trial: 8018004
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (rtPA, APSAC) with heparin
Trial: 824553
Drug: Physiotherapeutic exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapeutic exercise therapy with bencyclane (treatment group, n = 45)
Trial: 18474025
Drug: Intermittent high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent high dosage oral ibandronate
Trial: 18474025
Drug: Daily low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily low dose ibandronate
Trial: 15513977
Drug: Anastrozole ('Arimidex')
RxNorm normalized name: Anastrozole
DrugBank: Anastrozole (DB01217)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anastrozole ('Arimidex') alone or in combination with tamoxifen
Trial: 11996196
Drug: bisoprolol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg
Trial: 10535718
Drug: amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amlodipine 5 mg
Trial: 10215737
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of alendronate/day
Trial: 7630617
Drug: Medication reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication reduction
Trial: 31317460
Drug: Oxygen administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen administration through a nasopharyngeal airway and standard nasal cannula
Trial: 28067693
Drug: Intraoperative S-ketamine
RxNorm normalized name: (S)-(-)-ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative S-ketamine bolus 0.5 mg/kg and infusion 0.25 mg·kg·h
Trial: 24251378
Drug: Orlistat medication
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat medication therapy plus low-fat diet
Trial: 18639327
Drug: Tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine ER (4 mg once daily)
Trial: 11271790
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (500 mg daily) for 10 weeks
Trial: 8199416
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) providing 41 +/- 2 kcal, 0.30 +/- 0.02 g N kg‐1.day‐1, and 40 mg pyridoxine for 14 days.
Trial: 8199416
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation at a dosage of 8.6 mg.kg‐1.day‐1.
Trial: 27406028
Drug: FenuSMART™ (fenugreek
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FenuSMART™ (fenugreek extract) 1000 mg/day for 90 days
Trial: 24356886
Drug: Hi-Xen infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hi-Xen infusion at 12 pmol · kg(‐1) · min(‐1)
Trial: 24356886
Drug: Lo-Xen infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lo-Xen infusion at 4 pmol · kg(‐1) · min(‐1)
Trial: 24356886
Drug: Hi-Xen infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hi-Xen infusion for 90 or 300 min
Trial: 24356886
Drug: Hi-Xen infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hi-Xen infusion for 30 min
Trial: 24356886
Drug: Hi-Xen infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hi-Xen infusion
Trial: 18697894
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy intervention
Trial: 15855325
Drug: Pioglitazone (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (45 mg/day) for 12 weeks
Trial: 1833813
Drug: Clomipramine (CMP)
DrugBank: Clomipramine (DB01242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomipramine (CMP) administered at progressive doses for 8 days (maximum dosage 75 mg) in the evening at 6 p.m.
Trial: 1833813
Drug: Placebo (glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (glucose solution infusion) administered morning and evening.
Trial: 6801213
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (600 mg/day)
Trial: 30711528
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone (200 mg bid)
Trial: 22021897
Drug: Both DAS28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both DAS28 and MMP‐3‐driven therapy (T group)
Trial: 22021897
Drug: MMP‐3‐driven therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMP‐3‐driven therapy (M group)
Trial: 19346511
Drug: Metered-dose inhaler
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-dose inhaler (MDI) with 50 microg nicotine/puff
Trial: 19346511
Drug: Metered-dose inhaler
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-dose inhaler (MDI) with 100 microg nicotine/puff
Trial: 11229224
Drug: Aspirin (at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (at lower doses)
Trial: 7811344
Drug: S-adenosylmethionine (SAME);
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosylmethionine (SAME); 2 g daily in 250 ml 0.15 M NaCl for 15 days
Trial: 7811344
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (alcoholic patients without treatment)
Trial: 9511622
Drug: Myprodol (Ibuprofen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myprodol (Ibuprofen, Paracetamol and Codeine phosphate)
Trial: 332607
Drug: Antacids containing
RxNorm normalized name: antacids containing calcium compounds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacids containing Mg (OH)2, Al (OH)3 and CaCO3, administered after meals
Trial: 24377635
Drug: Had never
RxNorm normalized name: Haddock
DrugBank: Haddock (DB10615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Had never seen friends smoking in a school compound
Trial: 19305020
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg and Simvastatin 40 mg (coadministered)
Trial: 11704900
Drug: Behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural therapy (general)
Trial: 9491231
Drug: Loratadine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine (10 mg once daily for 7 days)
Trial: 7840417
Drug: Ketamine racemate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine racemate (1 mg/kg)
Trial: 7840417
Drug: S(+)‐ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S(+)‐ketamine (0.5 mg/kg)
Trial: 28662281
Drug: Monthly provider
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly provider funnel plot feedback reports and semiannual face‐to‐face coaching sessions for 12 months
Trial: 25970080
Drug: Autologous peripheral
RxNorm normalized name: Autologous peripheral blood-derived CD34+ cells
DrugBank: Autologous peripheral blood-derived CD34+ cells (DB16367)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous peripheral blood stem cell transplantation in addition to comprehensive medical treatment
Trial: 25970080
Drug: Comprehensive medical
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive medical treatment alone (Control)
Trial: 19551674
Drug: Bimatoprost 0.03%
RxNorm normalized name: BIMATOPROST 0.03% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost 0.03% once daily for 12 weeks
Trial: 15214959
Drug: Ofloxacin plus
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin plus rifampicin (400 mg/day plus 600 mg/day for 30 days)
Trial: 15214959
Drug: Doxycycline plus
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline plus rifampicin (200 mg/day plus 600 mg/day for 45 days)
Trial: 10737828
Drug: Multiple-family group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-family group psychoeducation treatment
Trial: 25758874
Drug: Gabapentin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (200 mg)
Trial: 25758874
Drug: Levodopa-c (110
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa-c (110 mg)
Trial: 23838349
Drug: Clofarabine 20
RxNorm normalized name: clofarabine 20 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofarabine 20 mg/m² on days 1 to 5 for up to 4 courses
Trial: 23838349
Drug: Low-dose Ara-C
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Ara-C (LDAC) 20 mg twice daily for 10 days every 6 weeks for up to 4 courses